GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tong Ren Tang Technologies Co Ltd (HKSE:01666) » Definitions » Total Equity

Tong Ren Tang Technologies Co (HKSE:01666) Total Equity : HK$10,600 Mil (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Tong Ren Tang Technologies Co Total Equity?

Tong Ren Tang Technologies Co's total equity for the quarter that ended in Jun. 2024 was HK$10,600 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Tong Ren Tang Technologies Co Total Equity Historical Data

The historical data trend for Tong Ren Tang Technologies Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tong Ren Tang Technologies Co Total Equity Chart

Tong Ren Tang Technologies Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,250.57 9,188.89 9,989.70 10,069.35 10,557.03

Tong Ren Tang Technologies Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,856.11 10,069.35 10,180.19 10,557.03 10,599.87

Tong Ren Tang Technologies Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Tong Ren Tang Technologies Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=14774.483-4217.455
=10,557

Tong Ren Tang Technologies Co's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=15382.646-4782.778
=10,600

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tong Ren Tang Technologies Co Total Equity Related Terms

Thank you for viewing the detailed overview of Tong Ren Tang Technologies Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Tong Ren Tang Technologies Co Business Description

Traded in Other Exchanges
Address
No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
Executives
Citigroup Inc. 2502 Approved lending agent
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Aberdeen Asset Management Plc And Its Associates 2102 Investment manager

Tong Ren Tang Technologies Co Headlines

No Headlines